[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Electrocore Inc (ECOR)

Electrocore Inc (ECOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 71,965
  • Shares Outstanding, K 8,296
  • Annual Sales, $ 32,030 K
  • Annual Income, $ -13,970 K
  • EBIT $ -15 M
  • EBITDA $ -14 M
  • 60-Month Beta 0.83
  • Price/Sales 2.36
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.41
  • Number of Estimates 2
  • High Estimate $-0.31
  • Low Estimate $-0.50
  • Prior Year $-0.35
  • Growth Rate Est. (year over year) -17.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.70 +52.54%
on 05/21/26
10.49 -17.15%
on 06/15/26
+2.42 (+38.68%)
since 05/15/26
3-Month
5.56 +56.27%
on 03/23/26
10.49 -17.15%
on 06/15/26
+1.88 (+27.68%)
since 03/17/26
52-Week
4.16 +109.01%
on 08/11/25
10.49 -17.15%
on 06/15/26
+3.61 (+71.16%)
since 06/17/25

Most Recent Stories

More News
electroCore to Participate in iAccess Alpha Virtual Best Ideas Summer Investment Conference

ROCKAWAY, N.J., June 17, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will participate in the iAccess...

ECOR : 8.69 (+0.23%)
Frontiers in Neuroscience Accepts Review Article Synthesizing Evidence that Cervical nVNS Activates the Vagus Nerve Without Surgery

ROCKAWAY, N.J., June 09, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that the review article, "Without getting...

ECOR : 8.69 (+0.23%)
electroCore to Present at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub

ROCKAWAY, N.J., June 02, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc.  (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be presenting at Planet...

ECOR : 8.69 (+0.23%)
electroCore Touts 30% Growth Outlook, VA Opportunity at LD Micro Conference

electroCore (NASDAQ:ECOR) Interim President and CFO Joshua Lev said the bioelectronic technology company is focused on expanding its non-invasive vagus nerve stimulation platform across federal health...

ECOR : 8.69 (+0.23%)
electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia

ROCKAWAY, N.J., May 13, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the publication of new clinical findings...

ECOR : 8.69 (+0.23%)
electroCore to Present at the LD Micro Invitational XVI Conference on May 18, 2026

ROCKAWAY, N.J., May 08, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be participating in the...

ECOR : 8.69 (+0.23%)
electroCore Announces First Quarter 2026 Financial Results

First quarter 2026 net sales of $9.6 million, an increase of 43% over $6.7 million in the first quarter 2025 Net loss of $5.3 million with Adjusted EBITDA net loss improving 24% from prior-year...

ECOR : 8.69 (+0.23%)
electroCore TAC-STIMâ„¢ Named National Semifinalist in National Safety Council Work to Zero Challenge

ROCKAWAY, N.J., April 30, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that TAC-STIMâ„¢, its non-invasive...

ECOR : 8.69 (+0.23%)
electroCore to Announce First Quarter March 31, 2026, Financial Results on Wednesday, May 6, 2026

ROCKAWAY, N.J., April 29, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial results...

ECOR : 8.69 (+0.23%)
electroCore to Present at the Market Movers Investor Summit on May 5, 2026

ROCKAWAY, N.J., April 28, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be participating in the...

ECOR : 8.69 (+0.23%)

Business Summary

electroCore Inc. is a commercial-stage bioelectronic medicine company. Its current indications are the preventative treatment of cluster headache and migraine and acute treatment of migraine and episodic cluster headache. electroCore Inc., formerly known as ELECTROCORE LLC, is based in LOS ANGELES, CA....

See More

Key Turning Points

3rd Resistance Point 9.51
2nd Resistance Point 9.27
1st Resistance Point 8.98
Last Price 8.69
1st Support Level 8.45
2nd Support Level 8.21
3rd Support Level 7.92

See More

52-Week High 10.49
Last Price 8.69
Fibonacci 61.8% 8.08
Fibonacci 50% 7.33
Fibonacci 38.2% 6.58
52-Week Low 4.16

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.